GSK Investigational Site

Chieri Torino 10023

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Respiratory Syncytial Virus Infections

Studies at this site

• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early